Data Showcase Imaging Agent Utility in Lung Cancer Surgery

Making lung tumors glow with the imaging agent pafolacianine leads to more thorough resections, trial data show; however, there's no survival data yet.

Related Keywords

Phoenix ,Arizona ,United States ,Inderpal Sarkaria ,Kristina Butler ,University Of Pittsburgh ,Cardiovascular Surgery ,Target Laboratories ,Medscape Medical News ,Mayo Clinic ,Lung Cancer ,Ung Carcinoma ,Ancer Lung ,Secondary Lung Tumor ,Malignant Secondary Lung Neoplasm ,Etastasis Lung ,Cancer ,Alignant Neoplasia ,Arcinoma ,Lung ,Ovarian Cancer ,Alignant Ovarian Neoplasm ,Lung Resection ,Pulmonary Resection ,Surgery ,Metastasis ,Tumor ,Computed Tomography ,It ,Presection ,Tissue ,Abdominal Pain ,Chest Pain ,Healthcare And Medical Technology ,Ealth And Medical Tech ,Health A ,